Clinical and serological features of patients with autoantibodies to GW/P bodies

Rahima A Bhanji1, Theophany Eystathioy, Edward K L Chan

  • 1Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, Canada.

Insights

Autoantibodies targeting GW bodies (GWBs) frequently react with Ge-1/Hedls, GW182, and Ago2 proteins. These anti-GWB antibodies are associated with Sjögren

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • GW bodies (GWBs) are crucial cytoplasmic structures regulating messenger RNA (mRNA) processing and RNA interference (RNAi).
  • GWBs contain key molecular machinery, including mRNA, RNA-induced silencing complex (RISC) components, microRNA (miRNA), and Argonaute proteins.

Purpose of the Study:

  • To identify specific autoantigens within GW bodies targeted by autoantibodies from patients with anti-GWB antibodies.
  • To correlate the presence of anti-GWB autoantibodies with specific clinical features in affected patients.

Main Methods:

  • Addressable laser bead immunoassay (ALBIA) was employed to analyze sera reactivity against recombinant proteins.
  • Immunoprecipitation assays were utilized to confirm autoantibody targets within GW bodies.
  • Clinical data from patients with anti-GWB antibodies were collected and analyzed.

Main Results:

  • Autoantibodies in the studied cohort predominantly targeted Ge-1/Hedls (58%), GW182 (40%), and Ago2 (16%).
  • Specific epitopes recognized included the N-terminus of Ago2 and the nuclear localization signal (NLS) region of Ge-1/Hedls.
  • Common clinical associations included neurological symptoms (33%), Sjögren's syndrome (31%), and reactivity to Ro52 (44%).

Conclusions:

  • Ge-1/Hedls is identified as a frequent target antigen in anti-GWB autoantibody sera.
  • A significant proportion of patients with anti-GWB antibodies present with Sjögren's syndrome and neurological disorders.
  • Anti-GWB autoantibodies may serve as potential biomarkers for specific autoimmune conditions.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...